| Q38135151 | A literature review of key molecular genetic aberrations in meningiomas: a potential role in the determination of radiosurgery outcomes |
| Q43894472 | A microRNA expression signature predicts meningioma recurrence |
| Q40867510 | A new patient-derived orthotopic malignant meningioma model treated with oncolytic herpes simplex virus. |
| Q54383059 | A phase II trial of PTK787/ZK 222584 in recurrent or progressive radiation and surgery refractory meningiomas. |
| Q36942228 | ARID1A and TERT promoter mutations in dedifferentiated meningioma |
| Q38944293 | Activation of multiple growth factor signalling pathways is frequent in meningiomas |
| Q36493804 | Alterations of oxidative phosphorylation in meningiomas and peripheral nerve sheath tumors |
| Q38905432 | Alternating electric tumor treating fields for treatment of glioblastoma: rationale, preclinical, and clinical studies. |
| Q40990375 | An analysis of prognostic factors associated with recurrence in the treatment of atypical meningiomas. |
| Q57163869 | An overview of meningiomas |
| Q43084857 | Angiomatous meningiomas have a distinct genetic profile with multiple chromosomal polysomies including polysomy of chromosome 5. |
| Q38827423 | Atypical and anaplastic meningioma: outcomes in a population based study |
| Q26820849 | Brain tumors: Special characters for research and banking |
| Q92446819 | Case-Based Review: meningioma |
| Q39355087 | Classification of Meningiomas Based on Their Surgical Removal, World Health Organization Grade, and Cytogenetic Profile: A Treatment Algorithm |
| Q38810583 | Classification of human meningiomas: lights, shadows, and future perspectives |
| Q35869572 | Convexity en plaque meningioma manifesting as subcutaneous mass: case report |
| Q34716061 | Curcumin acts anti-proliferative and pro-apoptotic in human meningiomas |
| Q35848234 | Development of patient-derived xenograft models from a spontaneously immortal low-grade meningioma cell line, KCI-MENG1. |
| Q36346636 | Double-Blind Phase III Randomized Trial of the Antiprogestin Agent Mifepristone in the Treatment of Unresectable Meningioma: SWOG S9005. |
| Q35905146 | Epigenetic Role of Histone 3 Lysine Methyltransferase and Demethylase in Regulating Apoptosis Predicting the Recurrence of Atypical Meningioma |
| Q41925124 | Epigenetics of Meningiomas |
| Q36483721 | Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes. |
| Q35170717 | Expression of c-MET in Invasive Meningioma |
| Q88371763 | Familial Syndromes Involving Meningiomas Provide Mechanistic Insight Into Sporadic Disease |
| Q35793582 | Genetic/molecular alterations of meningiomas and the signaling pathways targeted |
| Q50104280 | Genomic analysis of synchronous intracranial meningiomas with different histological grades |
| Q42548316 | Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations |
| Q53246945 | Hydroxyurea with or without imatinib in the treatment of recurrent or progressive meningiomas: a randomized phase II trial by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO). |
| Q38979594 | Hypoxia inducible factor-1 is involved in growth factor, glucocorticoid and hypoxia mediated regulation of vascular endothelial growth factor-A in human meningiomas. |
| Q87430784 | IFN-α for recurrent surgery- and radiation-refractory high-grade meningioma: a retrospective case series |
| Q55000194 | Identification of key genes and pathways in meningioma by bioinformatics analysis. |
| Q41922099 | Intracranial Meningioma in patients younger than 35 years of age: An evolution of the disease in the Era of Human Immunodeficiency Virus infection. A retrospective observational study |
| Q40045262 | Intracranial Meningiomas in the Era of Human Immunodeficiency Virus Infection and Antiretroviral Therapies in KwaZulu-Natal, South Africa: An Observational Case-Control Study |
| Q87430618 | Is there effective systemic therapy for recurrent surgery- and radiation-refractory meningioma? |
| Q36868537 | KINOMIC ALTERATIONS IN ATYPICAL MENINGIOMA. |
| Q41192778 | Large and giant skull base meningiomas: The role of radical surgical removal |
| Q55294739 | Meningioma in Fourth Ventricle of Brain: A Case Report and Literature Review. |
| Q34631513 | Molecular Targets and Treatment of Meningioma |
| Q39682528 | Molecular and genetic characterization of meningiomas: future predictive assays and "personalized" treatment |
| Q92817234 | Molecular characteristics of meningiomas |
| Q33840212 | Molecular progression in unusual recurrent non-pediatric intracranial clear cell meningioma. |
| Q35232689 | Molecular typing of Meningiomas by Desorption Electrospray Ionization Mass Spectrometry Imaging for Surgical Decision-Making |
| Q30375908 | Multiple Meningiomas in a Patient with Cowden Syndrome. |
| Q64102900 | Neurofibromatosis type 2 gene mutation and progesterone receptor messenger RNA expression in the pathogenesis of sporadic orbitocranial meningioma |
| Q52646651 | New drug candidates for treatment of atypical meningiomas: An integrated approach using gene expression signatures for drug repurposing. |
| Q90355643 | New insights into the genomic landscape of meningiomas identified FGFR3 in a subset of patients with favorable prognoses |
| Q54423416 | Perfusion heterogeneity in breast tumors for assessment of angiogenesis. |
| Q36386374 | Predictors of recurrence in the management of chordoid meningioma |
| Q93158618 | Preoperative and Histological Predictors of Recurrence and Survival in Atypical Meningioma After Initial Gross Total Resection |
| Q39495881 | Proteomics Analysis of Brain Meningiomas in Pursuit of Novel Biomarkers of the Aggressive Behavior |
| Q36888949 | Recurrence of Skull Base Meningiomas: The Role of Aggressive Removal in Surgical Treatment |
| Q41809124 | STAT3 activation and risk of recurrence in meningiomas |
| Q86729750 | Spinal Meningioma Resection |
| Q91462528 | Surgical Removal of Skull Base Meningiomas in Symptomatic Elderly Patients |
| Q48787594 | Systemic therapy for recurrent meningioma |
| Q47157082 | The Clinical Outcome of Hydroxyurea Chemotherapy after Incomplete Resection of Atypical Meningiomas |
| Q38997320 | The Emerging Role of TRAF7 in Tumor Development |
| Q53579500 | The Influence of Adjuvant Radiotherapy in Atypical and Anaplastic Meningiomas: A Series of 88 Patients in a Single Institution. |
| Q99711991 | The Preferred Locations of Meningioma According to Different Biological Characteristics Based on Voxel-Wise Analysis |
| Q27853347 | Transcriptomic analysis of aggressive meningiomas identifies PTTG1 and LEPR as prognostic biomarkers independent of WHO grade |
| Q88333494 | [Primary culture of human malignant meningioma cells and its intracranial orthotopic transplantation in nude mice] |